News

Filter

1 to 9 of 11 results

FDA Approves Abraxane for NSCLC and expands indication for Actemra

15-10-2012

The US Food and Drug Administration on Friday approved biotech firm Celgene's (Nasdaq: CELG) Abraxane…

AbraxaneActemraAnti-Arthritics/RheumaticsBiotechnologyCelgeneGenentechNorth AmericaOncologyPharmaceuticalRegulationRoche

Pfizer’s tasocitinib reduced signs and symptoms of rheumatoid arthritis in Ph III study; New data on Roche’s Actemra in RA

08-11-2010

A Phase III study, dubbed ORAL Solo (1045), has demonstrated that US pharma behemoth Pfizer’s (NYSE:…

ActemraAnti-Arthritics/RheumaticsGenentechPfizerPharmaceuticalResearchRochetasocitinib

Despite safety concerns, Actemra usage increases among TNF-refractory patients who have failed one or two biologics

14-05-2010

Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved…

ActemraAnti-Arthritics/RheumaticsGenentechMarkets & MarketingPharmaceuticalRoche

Rheumatologists eager to use Roche/Genentech's Actemra, according to new study

22-03-2010

Actemra (tocilizumab), marketed by Swiss drug major Roche and its US subsidiary Genentech, is the first…

ActemraAnti-Arthritics/RheumaticsBiotechnologyGenentechMarkets & MarketingPharmaceuticalRoche

1 to 9 of 11 results

Back to top